Friday, April 21, 2017 7:16:55 PM
Charles and Michal, management, received Series B Convertible preferred in exchange for the anti-dilution shares owed them in connection with their investment in the company in January 2015.
They just converted their series B to common stock and the Form 4 discloses that to the public. (Per company.)
WHY convert now, IDK. Did some restriction term expire?
If someone has the time to read the old filings pls. share.
But haven't some people here been saying there need to be fewer Preferred shares? So sounds like this would've added to commons O/S, but there's no mention of their wanting to sell -- historically Charles hadn't been selling his shares IF I recall correctly, I haven't paid close attn. since the R/S.
As a result some of these figures may have changed since 4/5/17:
The T/A will usually reveal current O/S.
Would assume the common shares increased per filing, Preferred decreased. NOT one-for-one, see the 8K.
BTCS Security Details
Share Structure
Market Value1 $2,706,853 a/o Apr 20, 2017
Authorized Shares 975,000,000 a/o Apr 06, 2017
Outstanding Shares 41,708,053 a/o Apr 06, 2017
-Restricted 20,973,067 a/o Apr 06, 2017
-Unrestricted 20,734,986 a/o Apr 06, 2017
Held at DTC 20,676,521 a/o Apr 06, 2017
Float 14,431,800 a/o Jan 16, 2017
Transfer Agent(s) Verified by Transfer Agent
Equity Stock Transfer
Equity Stock Transfer
Transfer Agent
237 W 37th St #601
New York, NY 10018
212-575-5757
http://www.equitystock.com
info@equitystock.com
Recent BTCS News
- BTCS Inc. Welcomes Ashley DeSimone to Its Board of Directors • GlobeNewswire Inc. • 04/18/2024 12:30:00 PM
- BTCS Reports 2023 Results • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:01:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/07/2024 12:18:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 12:35:59 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 06:49:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 10:00:25 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/14/2024 10:04:19 PM
- BTCS Inc. Launches Builder+ to Enhance Ethereum Blockchain Infrastructure • GlobeNewswire Inc. • 02/01/2024 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 10:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 01:55:34 PM
- BTCS Issues Shareholder Letter Reflecting on 2023 and Outlook for 2024 • GlobeNewswire Inc. • 01/24/2024 01:55:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:09:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:02:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 09:59:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 09:57:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:30:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:06:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:05:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:05:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:05:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:01:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:01:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:01:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 09:30:39 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM